AMG Veritas Global Focus N holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
AMG Veritas Global Focus Fund Class N MFQAX
- NAV / 1-Day Return 16.08 / −0.44 %
- Total Assets 23.9M
-
Adj. Expense Ratio
1.130%
- Expense Ratio 1.130%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Global Large-Stock Blend
- Investment Style Large Blend
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.56%
- Turnover 28%
USD | NAV as of Jun 08, 2026 | 1-Day Return as of Jun 08, 2026, 10:27 PM GMT+0
Morningstar’s Analysis MFQAX
Will MFQAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MFQAX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MFQAX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Amazon.com Inc | 6.18 | 1M | Consumer Cyclical |
UnitedHealth Group Inc | 5.86 | 1M | Healthcare |
Vinci SA | 5.55 | 1M | Industrials |
Canadian Pacific Kansas City Ltd | 5.06 | 1M | Industrials |
London Stock Exchange Group PLC | 4.79 | 1M | Financial Services |
Microsoft Corp | 4.58 | 1M | Technology |
Safran SA | 4.58 | 1M | Industrials |
Airbus SE | 4.55 | 1M | Industrials |
Mastercard Inc Class A | 4.22 | 1M | Financial Services |
Thermo Fisher Scientific Inc | 4.11 | 983,784 | Healthcare |
United States